Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Frontiers in Immunology|May 15, 2025
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experienceMadeline B Torres, Cheuk Hong Leung, Marianne Zoghbi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2021
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver MetastasesPreeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, et al.Cancer Discovery|September 13, 2022
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung AdenocarcinomaDapeng Hao, Guangchun Han, Ansam Sinjab, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung CancerAlejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable MelanomaElizabeth M Burton, Denái R Milton, Michael T Tetzlaff, et al.Acta Neuropathologica|July 20, 2021
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated stateVeena Kochat, Ayush T Raman, Sharon M Landers, et al.Nature|July 19, 2023
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cellsYogesh Goyal, Gianna T Busch, Maalavika Pillai, et al.Frontiers in Oncology|October 31, 2022
The immune landscape of undifferentiated pleomorphic sarcomaRossana Lazcano, Carmelia M Barreto, Ruth Salazar, et al.Nature Medicine|May 29, 2023
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistanceYanshuo Chu, Enyu Dai, Yating Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I TrialEdwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.Pageof 5